Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Equity Average (2016 - 2025)

Historic Equity Average for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $5.6 million.

  • Jaguar Health's Equity Average fell 6212.64% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 6212.64%. This contributed to the annual value of $5.7 million for FY2024, which is 22168.88% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Equity Average is $5.6 million, which was down 6212.64% from $3.9 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Equity Average ranged from a high of $31.8 million in Q2 2021 and a low of $1.1 million during Q4 2022
  • In the last 5 years, Jaguar Health's Equity Average had a median value of $6.7 million in 2023 and averaged $10.3 million.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 71877.33% in 2021, then crashed by 9328.54% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Equity Average stood at $16.7 million in 2021, then crashed by 93.29% to $1.1 million in 2022, then skyrocketed by 181.45% to $3.2 million in 2023, then skyrocketed by 210.33% to $9.8 million in 2024, then crashed by 42.63% to $5.6 million in 2025.
  • Its Equity Average stands at $5.6 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.7 million for Q1 2025.